For men facing prostate cancer, the common treatment options of surgery to remove the prostate gland, called prostatectomy, and radiation therapy to destroy cancer cells come with a frightening list of potential side effects, including incontinence and impotence. In light of recent studies that show many men with the disease will not die from it, patients are increasingly wondering whether treatment is worth the risk of reduced quality of life.
At the Siteman Cancer Center, our team of Washington University prostate cancer specialists is leading the way in determining what role screening should play and whether some men can avoid treatment by reducing their risk of developing the disease. Our researchers directed a national study examining the effectiveness of screening in reducing prostate cancer deaths. They also led an international study showing a common drug can reduce the chance of being diagnosed with prostate cancer in high-risk men.
For men who do require treatment, our prostate cancer team includes surgeons, radiation oncologists, medical oncologists, interventional radiologists and pathologists who offer a full spectrum of options tailored to each patient’s needs. Our team:
- Performs nearly 1,000 prostatectomies annually, including minimally invasive laparoscopic prostatectomies and robot-assisted prostatectomies
- Offers cryoablation, in which prostate cancer cells are frozen, and other investigational techniques to remove small tumors confined to the prostate instead of the entire prostate
- Provides a full range of radiation treatments, including brachytherapy, in which small radioactive seeds are placed near tumor cells, and external-beam therapy
Read about prostate cancer, including information about treatment and staging.
Prostate Cancer Podcasts
Listen to Siteman physicians discuss the latest advances in prostate cancer detection and care.
Learn about Siteman doctors who treat prostate cancer.
Know Your Risk
Complete a prostate cancer risk assessment.
For information or to make an appointment.